XML 82 R71.htm IDEA: XBRL DOCUMENT v3.5.0.2
Condensed Consolidating Statement Of Cash Flows (Details) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2016
Mar. 31, 2016
Jun. 30, 2015
Jun. 30, 2016
Jun. 30, 2015
Condensed Consolidating Financial Statements [Line Items]          
Net cash provided (used) by operating activities   $ (21,380)   $ 27,861 $ 42,543
CASH FLOWS FROM INVESTING ACTIVITIES:          
Investment in property and equipment       (10,912) (14,554)
Proceeds from sales of assets       1,700 6,283
Acquisitions of real estate       (25,389) 0
Contributions to equity method investments       (19,688) (2,446)
Distributions from equity method investments       3,619 270
Purchases of investments, employee benefit plans       (1,140) (1,736)
Proceeds from sales of investments, employee benefit plans       1,136 1,087
Issuance of mezzanine and other notes receivable       (13,048) (1,500)
Collections of mezzanine and other notes receivable       10,158 3,567
Advances to and investment in affiliates       0 0
Divestment in affiliates       0 0
Other items, net       (311) (261)
Net cash used by investing activities       (53,875) (9,290)
CASH FLOWS FROM FINANCING ACTIVITIES:          
Net borrowings pursuant to revolving credit facilities       87,950 13,000
Principal payments on long-term debt       (623) (6,169)
Purchases of treasury stock       (28,278) (6,244)
Dividends paid       (23,193) (22,940)
Proceeds from contributions from affiliates       0 0
Distributions to affiliates       0 0
Proceeds from exercise of stock options $ 100   $ 100 4,234 5,696
Net cash provided (used) by financing activities   62,627   40,090 (16,657)
Net change in cash and cash equivalents       14,076 16,596
Effect of foreign exchange rate changes on cash and cash equivalents       371 (825)
Cash and cash equivalents at beginning of period   193,441   193,441 214,879
Cash and cash equivalents at end of period 207,888   230,650 207,888 230,650
Parent          
Condensed Consolidating Financial Statements [Line Items]          
Net cash provided (used) by operating activities       (34,467) 25,952
CASH FLOWS FROM INVESTING ACTIVITIES:          
Investment in property and equipment       (6,427) (11,351)
Proceeds from sales of assets       0 29
Acquisitions of real estate       0  
Contributions to equity method investments       0 0
Distributions from equity method investments       0 0
Purchases of investments, employee benefit plans       0 0
Proceeds from sales of investments, employee benefit plans       0 0
Issuance of mezzanine and other notes receivable       (5,306) (1,500)
Collections of mezzanine and other notes receivable       10,158 3,567
Advances to and investment in affiliates       0 0
Divestment in affiliates       0 0
Other items, net       (322) (261)
Net cash used by investing activities       (1,897) (9,516)
CASH FLOWS FROM FINANCING ACTIVITIES:          
Net borrowings pursuant to revolving credit facilities       88,000 13,000
Principal payments on long-term debt       0 (5,625)
Purchases of treasury stock       (28,278) (6,244)
Dividends paid       (23,193) (22,940)
Proceeds from contributions from affiliates       0 0
Distributions to affiliates       0 0
Proceeds from exercise of stock options       4,234 5,696
Net cash provided (used) by financing activities       40,763 (16,113)
Net change in cash and cash equivalents       4,399 323
Effect of foreign exchange rate changes on cash and cash equivalents       0 0
Cash and cash equivalents at beginning of period   13,529   13,529 25,290
Cash and cash equivalents at end of period 17,928   25,613 17,928 25,613
Guarantor Subsidiaries          
Condensed Consolidating Financial Statements [Line Items]          
Net cash provided (used) by operating activities       45,562 (893)
CASH FLOWS FROM INVESTING ACTIVITIES:          
Investment in property and equipment       (4,261) (3,187)
Proceeds from sales of assets       0 4,661
Acquisitions of real estate       0  
Contributions to equity method investments       (19,648) (1,659)
Distributions from equity method investments       0 0
Purchases of investments, employee benefit plans       (1,140) (1,736)
Proceeds from sales of investments, employee benefit plans       1,136 1,087
Issuance of mezzanine and other notes receivable       0 0
Collections of mezzanine and other notes receivable       0 0
Advances to and investment in affiliates       (25,816) (35)
Divestment in affiliates       5,298 2,122
Other items, net       0 0
Net cash used by investing activities       (44,431) 1,253
CASH FLOWS FROM FINANCING ACTIVITIES:          
Net borrowings pursuant to revolving credit facilities       0 0
Principal payments on long-term debt       (368) (356)
Purchases of treasury stock       0 0
Dividends paid       0 0
Proceeds from contributions from affiliates       0 0
Distributions to affiliates       0 0
Proceeds from exercise of stock options       0 0
Net cash provided (used) by financing activities       (368) (356)
Net change in cash and cash equivalents       763 4
Effect of foreign exchange rate changes on cash and cash equivalents       0 0
Cash and cash equivalents at beginning of period   19   19 25
Cash and cash equivalents at end of period 782   29 782 29
Non-Guarantor Subsidiaries          
Condensed Consolidating Financial Statements [Line Items]          
Net cash provided (used) by operating activities       16,766 18,141
CASH FLOWS FROM INVESTING ACTIVITIES:          
Investment in property and equipment       (224) (16)
Proceeds from sales of assets       1,700 1,593
Acquisitions of real estate       (25,389)  
Contributions to equity method investments       (40) (787)
Distributions from equity method investments       3,619 270
Purchases of investments, employee benefit plans       0 0
Proceeds from sales of investments, employee benefit plans       0 0
Issuance of mezzanine and other notes receivable       (7,742) 0
Collections of mezzanine and other notes receivable       0 0
Advances to and investment in affiliates       0 0
Divestment in affiliates       0 0
Other items, net       11 0
Net cash used by investing activities       (28,065) 1,060
CASH FLOWS FROM FINANCING ACTIVITIES:          
Net borrowings pursuant to revolving credit facilities       (50) 0
Principal payments on long-term debt       (255) (188)
Purchases of treasury stock       0 0
Dividends paid       0 (657)
Proceeds from contributions from affiliates       25,816 35
Distributions to affiliates       (5,298) (2,122)
Proceeds from exercise of stock options       0 0
Net cash provided (used) by financing activities       20,213 (2,932)
Net change in cash and cash equivalents       8,914 16,269
Effect of foreign exchange rate changes on cash and cash equivalents       371 (825)
Cash and cash equivalents at beginning of period   179,893   179,893 189,564
Cash and cash equivalents at end of period 189,178   205,008 189,178 205,008
Eliminations          
Condensed Consolidating Financial Statements [Line Items]          
Net cash provided (used) by operating activities       0 (657)
CASH FLOWS FROM INVESTING ACTIVITIES:          
Investment in property and equipment       0 0
Proceeds from sales of assets       0 0
Acquisitions of real estate       0  
Contributions to equity method investments       0 0
Distributions from equity method investments       0 0
Purchases of investments, employee benefit plans       0 0
Proceeds from sales of investments, employee benefit plans       0 0
Issuance of mezzanine and other notes receivable       0 0
Collections of mezzanine and other notes receivable       0 0
Advances to and investment in affiliates       25,816 35
Divestment in affiliates       (5,298) (2,122)
Other items, net       0 0
Net cash used by investing activities       20,518 (2,087)
CASH FLOWS FROM FINANCING ACTIVITIES:          
Net borrowings pursuant to revolving credit facilities       0 0
Principal payments on long-term debt       0 0
Purchases of treasury stock       0 0
Dividends paid       0 657
Proceeds from contributions from affiliates       (25,816) (35)
Distributions to affiliates       5,298 2,122
Proceeds from exercise of stock options       0 0
Net cash provided (used) by financing activities       (20,518) 2,744
Net change in cash and cash equivalents       0 0
Effect of foreign exchange rate changes on cash and cash equivalents       0 0
Cash and cash equivalents at beginning of period   $ 0   0 0
Cash and cash equivalents at end of period $ 0   $ 0 $ 0 $ 0